The DOI matches its Crossref record; 144 of the 145 references it cites were found in a registry or an index.
Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
Open accessAbstract
Cardio-obstetrics has emerged as an important multidisciplinary field that requires a team approach to the management of cardiovascular disease during pregnancy. Cardiac conditions during pregnancy include hypertensive disorders, hypercholesterolemia, myocardial infarction, cardiomyopathies, arrhythmias, valvular disease, thromboembolic disease, aortic disease, and cerebrovascular diseases. Cardiovascular disease is the primary cause of pregnancy-related mortality in the United States. Advancing maternal age and preexisting comorbid conditions have contributed to the increased rates of maternal mortality. Preconception counseling by the multidisciplinary cardio-obstetrics team is essential for women with preexistent cardiac conditions or history of preeclampsia. Early involvement of the cardio-obstetrics team is critical to prevent maternal morbidity and mortality during the length of the pregnancy and 1 year postpartum. A general understanding of cardiovascular disease during pregnancy should be a core knowledge area for all cardiovascular and primary care clinicians. This scientific statement provides an overview of the diagnosis and management of cardiovascular disease during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Support from an interdisciplinary team that may include nutritionists, kinesiologists, pharmacists, and mental health specialists, in addition to obesity medicine specialists, can be particularly effective for facilitating lifestyle modification and weight loss.17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More timely initiation of therapy is associated with improved cardiovascular clinical outcomes among individuals with hypertension, diabetes, and dyslipidemias.18,53”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, recent evidence suggests that counseling related to risk reduction for CKM syndrome in high-risk women should start in the prenatal period and continue until the completion of postpartum follow-up visits for the mother and baby.16–18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the lack of CVD event reduction, lifestyle modification with behavior change, healthy dietary modification, and physical activity, resulting in weight loss of 5% to 10%, causes improvements in CKM risk factors including remission of T2D,17,18 with the CKM benefits of lifestyle modification observed across a range of populations and geographic settings.19”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“dysregulation of these changes leading to excess insulin resistance, adipose deposition, hypercoagulability, cardiac remodeling, and decreased vascular resistance,12,18 may result in APOs.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adverse CKM risk factor levels (overweight/obesity, hypertension, hypertriglyceridemia, diabetes, CKD) during the prepregnancy period are associated with increased risk of APOs.18,29”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While waist-hip ratio provides improved characterization of metabolic and cardiovascular risk than waist circumference, challenges of complexity of measurement and lack of standardization make it less ideal for use in clinical settings.18,29–32”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Using both BMI and waist circumference provides complementary prognostic information regarding risk for future metabolic derangements, incident CVD, and mortality.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Regular assessments of lipids, glycemia, and kidney function (eg, eGFR) are recommended with increasing frequency for higher CKM stages, as the risk for progressive metabolic and kidney disease increases along the CKM spectrum.13,18–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Through these mechanisms, adverse SDOH lead to CKM risk factor development.16–20”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Modest weight loss of 5% to 10% among patients with overweight or obesity and diabetes is associated with improvement in glycemic measures, BP, HDL-C, and triglycerides, among others. This can result in risk reduction for incident CKM risk factors such as diabetes and hypertension.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Average excess weight loss is greater with RYGB (56%) than LSG (46%),2,18 with persistent differences at 10 years.4”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Bupropion/naltrexone, phentermine/topiramate, and orlistat have all shown efficacy in improving glycemia, and the latter 2, in reducing BP.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Clinical trials have indicated a lack of heterogeneity in the effects of each class of these cardioprotective glucose-lowering therapies between those who were and were not taking the other agent.17–19,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In patients with symptomatic PAD, semaglutide increases walking distance.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Treatment of obesity-related HFpEF with the GLP-1–based therapies semaglutide and tirzepatide achieves improvements in HF patient-reported health status and quality of life, functional capacity as measured by the 6-minute walk distance (6MWD), and freedom from worsening HF events, including HF hospitalizations.1,3,17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One analysis was based on the results of the EMPEROR-PRESERVED trial, in which the effect of SLGT2i on cardiovascular mortality in HFpEF was not statistically significant (HR, 0.91; 95% CI, 0.76–1.09).”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Two high-quality simulation model–based cost-effectiveness analyses evaluated the economic value of adding SGLT2i therapy to prior GDMT in adults with symptomatic HFpEF, but neither study reported subgroup analyses by diabetes status.17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In a sensitivity analysis assuming a 9% cardiovascular mortality benefit, the ICER was $174 053 per QALY gained.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Prior studies performed using a US health care sector perspective and a lifetime analytic horizon noted that SGLT2i therapy was unlikely to be cost-effective for HFpEF, but that the incremental cost-effectiveness ratio was sensitive to the effect on mortality.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These analyses suggest that SGLT2i therapy is not cost-effective at current drug prices (incremental cost-effectiveness ratio ≥$120 000 per QALY gained), but these analyses pooled individuals with and without diabetes, and there may be additional cardiovascular and kidney benefits in individuals with diabetes.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fibrosis stage best predicts adverse outcomes in MASLD.1,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“a lower eGFR, higher UACR, and higher CKD stages are associated with VTE development and worse outcomes.16–20”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Women planning pregnancy with diabetes are at greater risk of experiencing APOs compared to women without diabetes or those who develop GDM.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“An effective response to obesity pharmacotherapy has historically been described as at least 5% of body weight loss after 3 months of treatment.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“MBS, which induces body weight loss of >20%, also improves OSA, and is associated with reductions in CV and renal events, and in cardiovascular and all-cause mortality among people with OSA.3,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C.-T., Fesmire, F. M., Franklin, B. A., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,797
Erbel (2014) · doi:10.1093/eurheartj/ehu281 · Cited by 4,451
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,920
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,544
WRITING GROUP MEMBERS, Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4739e · Cited by 2,346
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
Ferro, J. M., Canhão, P., Stam, J., Bousser, M., & Barinagarrementería, F. (2004) · Stroke · doi:10.1161/01.str.0000117571.76197.26 · Cited by 2,309
Research works printed but not linked: 2
- Martin, JA, Hamilton, BE, Osterman, MJK, Driscoll, AK, Drake, P. Births: final data for 2017. Natl Vital Stat Rep. 2018;67:1–50.
- 10.1136/hrt.2006.095240 · DOI
Cited by
Sorted by citations
Items 401–474 of 474
Asymptomatic Complete Heart Block in Pregnancy
Harish, A., Brilliant, J., Lankford, A. S., & Forbess, L. W. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.106861
Peripartum cardiomyopathy in an intensive care unit setting
ZAIDI, S. F., Prasad, A., Gangadhar, A. M., Khan, S. A., Zaidi, A. H., Mushtaq, M., Anil, G., & Surani, S. (2026) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v15.i1.113515
Point-of-Care Ultrasound in the Evaluation of Systolic Heart Failure During Pregnancy and Postpartum
Martins, J. G., Saad, A. F., Saade, G., Jones, M., & Pacheco, L. D. (2026) · American Journal of Perinatology · doi:10.1055/a-2820-3207
Impacto clínico y cardiovascular del embarazo en la mujer con síndrome de Marfan
Soto, M. E., Santos-Aragón, M., & de la Mora-Cervantes, R. (2026) · Gaceta Médica de México · doi:10.24875/gmm.25000243
Baharuddin, B., Akl, M. M., & Rumpa, F. A. (2026) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2026.2640640
Chung, E., Fang, Y.-J., & Konecny, F. A. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00018.2026
Pulmonary Embolism in Pregnancy
Eckman, J., Kottappalli, N., Gonsalves, C. F., & Billett, H. H. (2026) · Springer eBooks · doi:10.1007/978-3-030-70904-4_5-1
Yamane, N., Sagawa, M., Yamada, S., Sanada, H., Harimoto, S., Kan, Y., Tsunakake, M., Nakamura, H., & Kumagai, M. (2026) · Case Reports in Women s Health · doi:10.1016/j.crwh.2026.e00804
Fibrosing Mediastinitis in Pregnancy
Chinmay, P., Trivedi, D., Toussaint, W. N., Islam, K. M. S. U., Titus, H., Madala, N., Ray, C., & Sharma, G. K. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2025.106496
Self-citationHeart Diseases in Pregnancy: A Narrative Review
Neema, P. K., Kapoor, M., & Panidapu, N. (2026) · Journal of Indian College of Anaesthesiologists · doi:10.4103/jica.jica_10_26
Caruso, N. B., Koe, E., Majdalany, D. S., & Chambliss, L. R. (2026) · Cureus · doi:10.7759/cureus.107200
Souza, F. C. A., Fiuza, E. A., & Aoyama, E. D. A. (2026) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v12i4.25855
Brown, L., Zhao, Y., Dsouza, V., Pace, D. F., James, K., Powe, C. E., Churchill, T., Economy, K. E., Maddah, M., Ellinor, P. T., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102764
Self-citationLong-term impact of pregnancy complications: it is time to raise CVD awareness
Vanharen, Y., Berendoncks, A. V., Mannaerts, D., & Goossens, E. (2026) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvag086
Singh, R., Curran, Y., Ferguson, B., Wescott, A., Heydarpour, K., Flerlage, I., Virani, R., Yee, L. M., Sorond, F. A., Pandey, D. K., et al. (2026) · Sci · doi:10.3390/sci8050103
Schneck, E., Markmann, M., Bahadori, A., Iyoha, E., Oehmke, F., Axt-Fliedner, R., Wolter, A., Lüdemann, M., Zajonz, T. S., & Müller, M. (2026) · Die Anaesthesiologie · doi:10.1007/s00101-026-01690-2
Aggarwal, P., Derti, S., Yannamani, A., Newman, J. S., Tuli, R., Dargan, P., Indaram, M. B., & Kassis‐George, H. (2026) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2026.200649
Bridging the Gap Between Genetic Cardiomyopathies and Pregnancy
Rosario, K. F., Hussien, M., Grover, P. L., Witte, C., Agarwal, R., Skowronski, J. N., Quist‐Nelson, J., Kittleson, M. M., Peragallo, R., Davis, M. B., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102784
Electrical storm in pregnancy uncovering an arrhythmogenic cardiomyopathy: a case report
Sóñora-López, S., González-Fernández, V., Pascual, J. F., Galián-Gay, L., & Pijuan‐Domenech, A. (2026) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytag370
Cardio-Obstetrics Fundamentals for Fellows
Sarma, A., Hameed, A. B., Economy, K. E., Scott, N. S., Harrington, C. M., Valente, A. M., Prabhu, M., Wolfe, D. S., Davis, M. B., & Yeh, D. D. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102798
Self-citationvan Diepen, S., Rampersad, P. P., Luk, A. C., Dahiya, G., Zern, E. K., Alviar, C. L., Barnett, C. F., Bohula, E. A., Bartos, J. A., Slater, T. M., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001438
Cardiovascular disease in pregnancy
Singh, N. P., Kuberan, A., & Goldszmidt, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21917-7.00026-4
Mechanical Tricuspid Valve Thrombosis and Pregnancy
Etreros, M. M., Martínez, S. B., Valero, D. D., Padilla-Prieto, C., Domínguez, J. V., Sancho, J. M., Suñer, D. B., Puig, B. M., & Almela, V. J. D. (2026) · Life · doi:10.3390/life16060886
Pregnancy in adult congenital heart disease: Insights from a 10-year multicenter cohort
Campagni, L., Christophe, M., Schouvey, S., Casalta, A., Ovaert, C., Bretelle, F., & Blanc, J. (2026) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2026.103226
Valvular Heart Diseases in Pregnancy: Current Insights and Recent Advances
Shah, S., Keen, S., Hoffman, K. K., & Desai, M. Y. (2026) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-026-00476-y
Hormonelle Kontrazeption bei arteriellem kardiovaskulärem Risiko
Segerer, S. E. (2026) · Gynäkologische Endokrinologie · doi:10.1007/s10304-026-00690-0
Atrial Fibrillation and Atrial Flutter in Pregnancy: Epidemiology, Pathophysiology, and Management
Li‐Barton, J. Y., Watkins, V. Y., Snow, S. C., Kuller, J. A., & Federspiel, J. J. (2026) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001538
Mullangi, V. N., Folk, S. Y. L., Sharma, S., Belnavis, G., Macielak, S. L., Blais, D. M., Attar, T. T., Suter, B., & Marshall, W. H. (2026) · Clinical Case Reports · doi:10.1002/ccr3.72837
Preeclampsia as a Premature MI Risk Equivalent: A Tiered Framework for Cardiovascular Triage
Ahmad, M., Khan, R. A., Kalsoom, Ali, K., Shakeel, S., Ayesha, Hameed, E., & Afzal, M. A. (2026) · Indus journal of bioscience research. · doi:10.70749/ijbr.v4i4.3133
Severe Hypertriglyceridemia Managed in a Pregnant Patient Using Nonstatin Therapies
Roy, R., Altenberg, M., Faulkner, S., Dickens, L. T., Horan, M., Davidson, M., & Patel, H. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.108753
Latif, Z., Mark, J. D., Makuvire, T. T., Batista, J. L. L., Oliveros, E., Lau, E. S., Sharma, G. V., & DeFilippis, E. M. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102934
Self-citationPostpartum heart failure unmasking unilateral absence of the right pulmonary artery: a case report
Bayo, D. F., Lyamuya, F. S., Ndale, E. K., Mwantake, M. R., Mpagama, J. R., Mbise, P., Lwiza, A. F., Peter, S. C., Mteta, V. A., Sadiq, A. M., et al. (2026) · Journal of Rare Diseases · doi:10.1007/s44162-026-00215-0
Somalo-Barranco, G., Benachi, A., Boon, L. M., Borgards, P., Dickinson, J. C., Droege, F., Dupuis, O., Frank, M., Jondeau, G., Kauling, R. M., et al. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04472-6
Changes in Retinal Microvasculature During Healthy Pregnancy Measured by AO
Dathan‐Stumpf, A., Martini, E., Stepan, H., Kolář, R., & Rauscher, F. G. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26521
Olorunyomi, G., Torres, C., Jones, J., Norwood, K., Idowu, K. A., Pounds, K., King, D., Ajewole, V. B., Poon, I., & Olaleye, E. A. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1793225
Congenital Heart Disease and Pregnancy
Westhoff‐Bleck, M., Bauersachs, J. K., Beerbaum, P., & von Kaisenberg, C. (2026) · Springer eBooks · doi:10.1007/978-3-662-70578-0_29
Ambarwati, R., Tan, M., & Ng, I. (2025) · Research Psychologie Orientation et Conseil · doi:10.70177/rpoc.v2i2.1859
The Influence of Art Therapy in Counseling: Enhancing Psychological Wellbeing
Ahmed, D., Kamal, M., & Al-Ansari, R. (2025) · Research Psychologie Orientation et Conseil · doi:10.70177/rpoc.v2i2.1858
Musmulyadin, M., Jun, W., & Mei, C. (2025) · Research Psychologie Orientation et Conseil · doi:10.70177/rpoc.v2i1.1857
Mehta, A., DeFilippis, E. M., & Shah, P. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001327
Factores de riesgo obstétricos en las embarazadas en el Centro de Salud Tipo C- Machala
Viscaino, C. A. V., & Salinas, S. M. S. (2026) · Salud Medicina e Innovación Journal · doi:10.70577/sc89h381
Kanjwal, S., Rice, S., Shan, Y., Giordano, S. H., Kuo, Y., & Lopez, D. S. (2026) · Research Square · doi:10.21203/rs.3.rs-9861573/v1
Resuscitation in pregnant women – the current international guidelines under close scrutiny
Strauss, A. S., Haupt, O., Gräsner, J., & Jacobsen, N. (2026) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-2892-2999
Johnston, A., Petrcich, W., Smith, G. N., Tanuseputro, P., Lee, D. S., Coutinho, T. A., & Edwards, J. D. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.046265
Jonas, R., Planek, M. I. C., Hu, T., Evans, E., Brandon, M., Hankins, J., Patel, P., Arif, S., Thakker, J., Li, S., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.043814
Self-citationImpact of Hypercholesterolemia on Pregnancy and Postpartum
Goldstein, A. K., Fisher, M. B., Trivedi, V., & Florio, K. L. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.06.003
Complex Aortic Surgery: Improving Outcomes Through Innovation and Protocol Optimization
Fuentes, L. M., Guadalupi, C., & Arnaoutakis, G. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-26073-4_13
Postpartum Follow-Up for Cardiovascular Disease Provoked by Pregnancy
Reiger, S., Buber, J., & Albright, C. M. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.07.006
Cheng, J., Yu, F., & Ye, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1914342
Mwemezi, P., Nyakunga, G. B., Lwiza, A. F., Peter, S. C., Lazarus, H., Kyilyosudu, H., Kabuka, B., & Sadiq, A. M. (2026) · Clinical Medicine Insights Cardiology · doi:10.1177/11795468261479407
Pregnancy-associated extracorporeal life support: insights from a nationwide dual-cohort analysis
Chang, F., Cheng, Y., Hsieh, M., Lin, C., Chen, C., Hsiao, F., Chang, C., Chan, Y., Wu, V. C., & Chen, S. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2026.07.015
Urgent Mitral Commissurotomy During Labor in Critical Rheumatic Mitral Stenosis
GUEDIRA, M., Hibatouallah, H., Soufiani, A., Bendagha, N., & Fellat, N. (2026) · Cureus · doi:10.7759/cureus.115113
Pregnancy-Associated Myocardial Infarction: Mechanisms, Diagnosis, Management, and Postpartum Risk
Radoi, A., Tarniceriu, M., Donisan, T., Rose, C. H., Tweet, M. S., & Young, K. A. (2026) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-026-00789-w
Vanharen, Y., Mannaerts, D., Kauling, R. M., Roos‐Hesselink, J. W., Cornette, J. M. J., Trongthiang, N., Goossens, E., & Berendoncks, A. V. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115397
Cardio-Obstetrics: A Critical Framework for Reducing Cardiovascular-related Maternal Mortality
Fitzgerald, K., Pham, A. B. N., Torosyan, N., Dhoon, T. Q., & Hameed, A. B. (2026) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-026-00788-x
Trauma in Pregnancy: Perioperative Assessment and Anesthetic Management
Hegde, N., Zunder, J. S., Nathwani, R. V., & Obelcz, Y. (2026) · Current anesthesiology reports · doi:10.1007/s40140-026-00730-2
Acute Limb Ischemia During Pregnancy: A Case Report and Narrative Review of the Literature
Annesi, L., Saric, E., Tossetta, G., Stern, C., Agnoletti, D., Potena, L., Borghi, C., & Piani, F. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15187188
Common Arrhythmias in Pregnancy
Aladesanmi, O., & Spiel, M. H. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.06.001
Cardiovascular Diseases Requiring Referral
Landres, I. V., Staniczenko, A. P., Gaur, P., & Singh, H. S. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.07.005
Preconception Evaluation for Cardiovascular Disease
Wilkie, G., & O’Day, K. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.06.002
Venous Thromboembolism in Pregnancy
Huynh, K. Z., Olevsky, O., & Mok, T. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.07.001
Clinical and cardiovascular impact of pregnancy in women with Marfan syndrome
Soto, M. E., Santos-Aragón, M., & de la Mora-Cervantes, R. (2026) · Gaceta Médica de México · doi:10.24875/gmm.m26001111
Pregnancy-associated cardiac complications
Thordsen, S., & Arany, Z. P. (2026) · Med · doi:10.1016/j.medj.2026.101301
Proteomic signatures during pregnancy: an exploratory cohort study of long-term health indicators
Bartho, L. A., Walker, S. P., MacDonald, T. M., Idzes, D., Cannon, P., Nguyen, T. V., Smith, G., Jones, D. S., Tong, S., & Kaitu’u‐Lino, T. J. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106491
Chua, A. Y. T., Mokrytzki, S., Hsueh, C., Tabtabai, S., Joseph, P., Elder, R. W., & Chavez, P. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.110391
Koller, Á., & Takács, J. (2026) · Clinics · doi:10.1016/j.clinsp.2026.101177
Tanyeri, S., Kültürsay, B., Karaçam, M., Çeneli, D., Yücel, E., & Karagöz, A. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2743947
Cardiovascular Medications in Pregnancy and Lactation: Safety and Clinical Decision-Making
Contractor, A., Torre, E., & Halpern, D. G. (2026) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-026-00790-3
Racial, Ethnic, and Socioeconomic Disparities in Cardio-Obstetrics.
Young, O. M., Smith, G., Skowronski, J., Mapatano, S. H., Wade, M., & Mallampati, D. P. (2026) · Clinical obstetrics and gynecology · doi:10.1097/grf.0000000000001060
Batista, P. K. A., Huntermann, R., Montenegro, M. V., Silva, R. R. A. D. S., Molinari, M. E., de Lucena, L. A., Dandamudi, M., Bacca, C. D. O. F., & Giorgi, J. M. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115491
Tweet, M. S., Santos, J., & Scott, N. S. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.110279
Kim, J., Schehr, A., & Ding, Y. (2026) · Brain Circulation · doi:10.4103/bc.bc_184_26
Hauspurg, A. K., Haas, D. M., Hoffman, M., Merz, C. N. B., Ranzini, A. C., Yee, L. M., Levine, L. D., Pemberton, V. L., Catov, J. M., & Grobman, W. (2026) · Pregnancy · doi:10.1002/pmf2.70491
Cavegn, C., Anastasiadou, E., Lünnemann, M., Brun, R., Button, D. A., & Madjdpour, C. (2026) · Case Reports in Anesthesiology · doi:10.1155/cria/4477329
Metadata
- Authors
- Mehta, L. S., Warnes, C. A., Bradley, E., Burton, T., Economy, K., Mehran, R., Safdar, B., Sharma, G., Wood, M., Valente, A. M., Volgman, A. S., & On behalf of the American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. A. S. C.
- ORCID
- Venue
- Circulation
- Published
- 2020-06-09
- Volume
- 141
- Issue
- 23
- Pages
- e884-e903
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3022591273
- Semantic Scholar
- a4f99c537a938a755723900351845a99644d8796
- Cited by
- 464
- References
- 145
- Citations by year
- 2026: 96 · 2025: 69 · 2024: 70 · 2023: 81 · 2022: 75 · 2021: 56 · 2020: 17
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Issues in Pregnancy
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- cardiovascular disease in pregnancy, cardio-obstetrics, maternal mortality, hypertensive disorders of pregnancy, preeclampsia, hypercholesterolemia, myocardial infarction, cardiomyopathy, cardiac arrhythmias, valvular heart disease, thromboembolism, aortic disease, cerebrovascular disease, preconception counseling, maternal morbidity, postpartum care
- MeSH terms
- American Heart Association, Female, Humans, Postnatal Care, Pregnancy, Pregnancy Complications, Cardiovascular, United States, Delivery, Obstetric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
